← Back to Treatments
🏅 FDA Orphan Designation

Tiglutik

riluzole oral suspension

Manufacturer: Italfarmaco SpA

Indicated for:
Amyotrophic Lateral Sclerosis (ALS)Orphan

FDA-Approved Indications (1)

TIGLUTIK is indicated for the treatment of amyotrophic lateral sclerosis (ALS).

Indications & Usage

1 INDICATIONS AND USAGE TIGLUTIK is indicated for the treatment of amyotrophic lateral sclerosis (ALS). TIGLUTIK is indicated for the treatment of amyotrophic lateral sclerosis (ALS) ( 1 )

Medical disclaimer: This information is for educational purposes only. Always consult a qualified healthcare provider before making treatment decisions. Data sourced from FDA and current as of our last update.